Skip to main content
Equibles

Vamil Devan

Analyst

Guggenheim Securities

Equibles does not estimate personal net worth.

About Vamil Devan

Vamil Devan is recorded as Analyst at Guggenheim Securities. Vamil Devan has spoken on 1 earnings call across 1 company, most recently for Johnson & Johnson on July 15, 2026. The companies whose calls Vamil Devan spoke on are classified in the Healthcare sector.

Vamil Devan on recent calls

“Maybe following up on similar to my question on IcoTide, I was hoping to get a little more color on Inlexo and the progress you're making there. I know you said sort of one in three eligible patients now receiving it, and inflation's up.”
Analyst — Guggenheim Securities, Johnson & Johnson Second Quarter 2026 Earnings Call ·

Affiliation history

  • Guggenheim Securities

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity